3-dimensional Sensor Technology to Quantify Leg-edema
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01700023|
Recruitment Status : Unknown
Verified October 2012 by Medical University of Graz.
Recruitment status was: Recruiting
First Posted : October 4, 2012
Last Update Posted : October 4, 2012
The purpose of the study is two-fold:
- to test 3-dimensional reconstruction of leg-edema in patients hospitalized for acute heart failure with leg-edema.
- to measure changes in QRS-morphology in a simulation of conventional blood-pressure measurement in patients hospitalized for acute heart failure.
|Condition or disease|
Leg-edema are common in patients with worsening heart failure. Apart from using a measuring tape there is no standardized tool to quantify leg-edema. Consequently, in patents with heart failure early detection of leg-edema is quite difficult.
From earlier pacemaker-studies it has been shown that an increase of afterload changes ECG-signals. Currently it is unknown how simple diagnostic procedures such as measuring blood-pressure affect QRS-morphology in patients with heart failure.
|Study Type :||Observational|
|Estimated Enrollment :||15 participants|
|Official Title:||Pilot-study HI-SENS: Innovative Sensor Technology to Quantify Cardiac Control Mechanisms in Heart Failure|
|Study Start Date :||September 2012|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||March 2013|
patients with leg-edema
patients with decompensated heart failure presenting with leg-edema
- accuracy of 3-dimensional measurements [ Time Frame: 10 days ]the 3-D camera will record changes in leg-shape around the ankles that result from reabsorption of fluid. These changes will be compared with changes in leg-circumference using a measuring tape
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700023
|Graz, Austria, 8036|
|Contact: Friedrich M Fruhwald, MD +43316385 ext 12544 firstname.lastname@example.org|
|Principal Investigator:||Friedrich M Fruhwald, MD||Medical University of Graz|